Related Experiment Video
Updated: Jun 23, 2026

12:03
Detection of Microregional Hypoxia in Mouse Cerebral Cortex by Two-photon Imaging of Endogenous NADH Fluorescence
Published on: February 21, 2012
16.1K
On-Chip NADH Detection in Multicellular Models Using an AlGaN/GaN Photodetector Array with Enhanced Sensitivity
Zhongshu Xiong1, Guocheng Fang1, Ramit Kumar Mondal1
1School of Electrical and Electronics Engineering, Nanyang Technological University, 50 Nanyang Ave., Singapore 639798, Singapore.
Nano Letters
|October 30, 2024
Summary
A novel photoelectric sensor array enables sensitive detection of Nicotinamide adenine dinucleotide (NADH). This advancement offers rapid quantification for cancer screening and point-of-care diagnostics.
Area of Science:
- Biomedical Engineering
- Analytical Chemistry
- Biophysics
Background:
- Nicotinamide adenine dinucleotide (NAD) is crucial for cellular redox reactions, energy metabolism, and cancer.
- Existing NADH detection methods often rely on complex optical measurements.
- There is a need for rapid, sensitive, and miniaturized NADH quantification techniques.
Purpose of the Study:
- To develop a miniaturized, on-chip photoelectric sensor array for sensitive NADH quantification.
- To utilize AlGaN/GaN two-dimensional electron gas (2DEG) photodetectors for NADH detection.
- To provide an advanced platform for biomedical research and clinical diagnostics.
Main Methods:
- Fabrication of a miniaturized photoelectric sensor array using AlGaN/GaN 2DEG photodetectors.
- Exploitation of the absorbance difference between NADH and NAD+ for quantification.
- Testing the sensor's performance with 3D multicellular models.
Main Results:
- The developed sensor exhibits ultralow dark current and ultrahigh UV light responsivity.
- Achieved rapid and sensitive NADH detection, outperforming commercial assays.
- Successfully detected NADH levels in complex 3D multicellular models.
Conclusions:
- The AlGaN/GaN 2DEG photodetector-based sensor offers a significant advancement in NADH quantification.
- The sensor platform holds potential for high-throughput testing and point-of-care diagnostics.
- This approach addresses the demand for efficient NADH sensing in biomedical and clinical settings.

